carbazilquinone has been researched along with Thrombocythemia, Essential in 3 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Thrombocythemia, Essential: A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higuchi, T | 1 |
| Okada, S | 1 |
| Mori, H | 1 |
| Niikura, H | 1 |
| Omine, M | 1 |
| Terada, H | 1 |
| Tabata, M | 1 |
| Imagawa, S | 1 |
| Tarumoto, T | 1 |
| Ohmine, K | 1 |
| Hatake, K | 1 |
| Miura, Y | 1 |
| Ozawa, K | 1 |
| Yonekura, S | 1 |
| Nagao, T | 1 |
| Arimori, S | 1 |
3 other studies available for carbazilquinone and Thrombocythemia, Essential
| Article | Year |
|---|---|
Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agent.
Topics: Adult; Aged; Carbazilquinone; Chromosome Aberrations; Female; Follow-Up Studies; Humans; Leukemia, M | 1995 |
Essential thrombocythemia transformed to acute myelogenous leukemia with t(3;17)(p24; q12), del(5)(q13q34) after treatment with carboquone and hydroxyurea.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Carbazilquinone; Chromosomes, Human, P | 2000 |
Essential thrombocythemia developing into refractory anemia and complicated by acute myeloid leukemia.
Topics: Aged; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cytarabin | 1992 |